Wolverine Trading’s Enovix ENVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.23M Buy
280,125
+14,839
+6% +$131K ﹤0.01% 2075
2025
Q2
$1.84M Sell
265,286
-51,143
-16% -$267K ﹤0.01% 1773
2025
Q1
$1.66M Buy
316,429
+36,715
+13% +$261K ﹤0.01% 1774
2024
Q4
$2.15M Sell
279,714
-6,572
-2% -$46.1K ﹤0.01% 1900
2024
Q3
$1.91M Sell
286,286
-187,143
-40% -$1.55M ﹤0.01% 1725
2024
Q2
$5.12M Buy
473,429
+241,286
+104% +$1.61M 0.01% 979
2024
Q1
$1.3M Sell
232,143
-485,000
-68% -$3.37M ﹤0.01% 1965
2023
Q4
$6.29M Sell
717,143
-91,286
-11% -$717K 0.01% 949
2023
Q3
$7.1M Sell
808,429
-503,857
-38% -$5.76M 0.01% 794
2023
Q2
$16.5M Buy
1,312,286
+450,715
+52% +$4.19M 0.02% 413
2023
Q1
$8.56M Buy
861,571
+425,000
+97% +$2.79M 0.01% 599
2022
Q4
$3.8M Buy
436,571
+249,142
+133% +$2.45M 0.01% 1031
2022
Q3
$2.3M Buy
187,429
+142,715
+319% +$1.69M ﹤0.01% 1315
2022
Q2
$278K Buy
+44,714
New +$336K ﹤0.01% 3153

Other funds holding ENVX

Wolverine Trading's ENVX Position: Q3 2025 in Review

Wolverine Trading reduced its Enovix (ENVX) stake by 45% in Q3 2025, selling an estimated $784K and leaving 109,531 shares worth $874K. The position accounts for ﹤0.01% of the portfolio, ranked #3040.

Wolverine Trading first reported a position in ENVX in Q2 2022 and has held it in 13 quarters since. The position peaked at $5.44M in Q1 2023. 320 funds tracked by Wall St. Rank hold ENVX as of Q3 2025.

  • Wolverine Trading held 109,531 shares of Enovix worth $874K as of Q3 2025.
  • Wolverine Trading sold 88,573 Enovix shares in Q3 2025, an estimated $784K.
  • Enovix made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #3040 holding.
  • Wolverine Trading first reported a position in Enovix in Q2 2022 and has held it in 13 quarters since.
  • Wolverine Trading's Enovix position peaked at $5.44M in Q1 2023.
  • 320 funds tracked by Wall St. Rank held Enovix as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.